↓ Skip to main content

Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin

Overview of attention for article published in Frontiers in Pharmacology, March 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
Published in
Frontiers in Pharmacology, March 2022
DOI 10.3389/fphar.2022.784459
Pubmed ID
Authors

Clifford J. Bailey, Mike Gwilt

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 7%
Student > Ph. D. Student 4 6%
Student > Master 3 4%
Researcher 3 4%
Professor > Associate Professor 2 3%
Other 3 4%
Unknown 51 72%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 4 6%
Medicine and Dentistry 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Neuroscience 2 3%
Other 3 4%
Unknown 51 72%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2023.
All research outputs
#6,607,718
of 24,076,257 outputs
Outputs from Frontiers in Pharmacology
#2,782
of 17,940 outputs
Outputs of similar age
#130,853
of 427,864 outputs
Outputs of similar age from Frontiers in Pharmacology
#158
of 1,239 outputs
Altmetric has tracked 24,076,257 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 17,940 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 1,239 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.